EBRO 2017

ESGO 2016

• Based on evidence from other squamous cell cancers such as cervical, head & neck, and anal cancer, the addition of concomitant, radiosensitising chemotherapy to adjuvant radiotherapy should be considered.

Grade C: Extrapolated evidence from studies rated as 2++